EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)

C Couselo-Rodríguez, A Batalla, J M Carrascosa, P Chicharro, A González-Quesada, P de la Cueva, A M Giménez-Arnau, Y Gilaberte, M Rodríguez-Serna, T Montero-Vilchez, R Ruiz-Villaverde, M Elosua-González und 18 weitere

Actas Dermo-Sifiliográficas · 2024

DOI: 10.1016/j.ad.2023.07.028 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Actas Dermo-Sifiliográficas, 2024. Verfasst von C Couselo-Rodríguez und 29 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Grupo de Investigación DIPO, Instituto de Investigaci…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Psoriasis. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The past 5 years have seen a proliferation of new treatments for atopic dermatitis (AD). We analyzed recent drug survival data for cyclosporine in this setting. Because the Spanish National Healthcare system requires patients with AD to be treated with cyclosporine before they can be prescribed other systemic treatments, drug survival for cyclosporine may be shorter than in other diseases. MATERIAL AND METHOD: Multicenter, observational, prospective cohort study using data from the Spanish Atopic Dermatitis Registry (BIOBADATOP). Data from the Spanish Registry of Systemic Treatments in Psoriasis (BIOBADADERM) were used to create a comparison cohort. RESULTS: We analyzed data for 130 patients with AD treated with cyclosporine (median drug survival, 1 year). Median cyclosporine survival in the psoriasis comparison group (150 patients) was 0.37 years. Drug survival was significantly longer in AD than in psoriasis (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicPsoriasisHumansCyclosporineImmunosuppressive AgentsProspective StudiesRegistriesTreatment Outcome

Stichwörter der Autor:innen

Análisis de supervivenciaAtopic dermatitisCiclosporinaCyclosporineDermatitis atópicaSurvival analysis

Substanzen

CyclosporineImmunosuppressive Agents

Autor:innen und Institutionen

  • Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Spain. Elect…
  • Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Spain.
  • Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol. Germans Trias I Pujol Research Institute (IGTP), Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.
  • Servicio de Dermatología, Hospital Universitario de la Princesa, Madrid, Spain.
  • Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
  • Servicio de Dermatología, Hospital Universitario Infanta Leonor, Madrid, Spain.

Zitieren

APA

Couselo-Rodríguez, C., Batalla, A., Carrascosa, J. M., Chicharro, P., González-Quesada, A., de la Cueva, P., Giménez-Arnau, A. M., Gilaberte, Y., Rodríguez-Serna, M., Montero-Vilchez, T., Ruiz-Villaverde, R., Elosua-González, M., Silvestre-Salvador, J. F., Munera-Campos, M., Sánchez-Pérez, J., Carretero, G., Mauleón-Fernández, C., Curto-Barredo, L., Ballano-Ruiz, A., …, & Flórez, Á. (2024). [Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). Actas Dermo-Sifiliográficas. https://doi.org/10.1016/j.ad.2023.07.028

Vancouver

Couselo-Rodríguez C, Batalla A, Carrascosa JM, Chicharro P, González-Quesada A, de la Cueva P, et al. [Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP). Actas Dermo-Sifiliográficas. 2024. doi:10.1016/j.ad.2023.07.028

BibTeX
@article{CouseloRodrguez2024,
  author = {Couselo-Rodríguez, C and Batalla, A and Carrascosa, J M and Chicharro, P and González-Quesada, A and de la Cueva, P and Giménez-Arnau, A M and Gilaberte, Y and Rodríguez-Serna, M and Montero-Vilchez, T and Ruiz-Villaverde, R and Elosua-González, M and Silvestre-Salvador, J F and Munera-Campos, M and Sánchez-Pérez, J and Carretero, G and Mauleón-Fernández, C and Curto-Barredo, L and Ballano-Ruiz, A and Botella-Estrada, R and Arias-Santiago, S and Navarro-Triviño, F J and Roustan-Gullón, G and Betlloch, I and Del Alcázar, E and Abalde-Pintos, M T and Suárez-Perez, J and García-Doval, I and Descalzo, M Á and Flórez, Á},
  title = {[Translated article] Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)},
  journal = {Actas Dermo-Sifiliográficas},
  year = {2024},
  doi = {10.1016/j.ad.2023.07.028}
}
Kostenlos starten →